Rossari Biotech Limited (ROSSARI) — Announcement

· NSE Neutral
📢 Key Event
Commercial production begins at Thailand blending facility
💡 Investor Takeaway
Shareholders gain exposure to Southeast Asian markets through this new manufacturing hub.

Rossari Biotech announced that its newly acquired Thai subsidiary Unistar Thai has commenced commercial production at a 5,000 MTPA blending facility in Thailand, strategically positioned to serve Southeast Asian markets with customized formulations and enhanced supply chain resilience. The facility, established after the December 10, 2024 acquisition, supports powders, granules and liquids manufacturing while ensuring operational efficiency and regional market agility.

📄 View Original Announcement (PDF)

About Rossari Biotech Limited (ROSSARI)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹2,806 Cr P/E: 20.6

View full ROSSARI stock details →

📡 Get AI alerts when ROSSARI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ROSSARI — Free

📊 More ROSSARI filings

See all ROSSARI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ROSSARI files new disclosures

Track ROSSARI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ROSSARI — Free

Free account · 2 AI queries/day